Tokyo, Jan. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060186) titled 'Verification of the effectiveness of radon bath therapy for rheumatoid arthritis' on Jan. 30.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Kobe City Medical Center General Hospital
Condition:
Condition - Rheumatoid Arthritis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Verification of effectiveness of radon bath therapy for rheumatoid arthritis
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Bathing using radon-emitting ceramics, performed for 20 minutes per session, at least 5 days per week for 2 weeks.
Interventions/Control_2 - Bathing using non-radon-emitting ceramics, performed for 20 minutes per session, at least 5 days per week for 2 weeks.
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with rheumatoid arthritis (RA) who meet the 2010 ACR/EULAR classification criteria or the 1987 ACR classification criteria for RA, with low to moderate disease activity (CDAI 2.8-22.0), and who have been relatively stable with no changes in antirheumatic therapy for at least 3 months.
Key exclusion criteria - Patients scheduled for changes in antirheumatic therapy (addition or dose escalation)
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 01 Month 30 Day
Anticipated trial start date - 2026 Year 01 Month 31 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068842
Disclaimer: Curated by HT Syndication.
